Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Moodys
UBS
Harvard Business School
Cipla
McKinsey
Citi
Novartis
Express Scripts

Generated: February 20, 2018

DrugPatentWatch Database Preview

GANITE Drug Profile

« Back to Dashboard

When do Ganite patents expire, and what generic alternatives are available?

Ganite is a drug marketed by Chapter 7 Trustee and is included in one NDA.

The generic ingredient in GANITE is gallium nitrate. There are fifteen drug master file entries for this compound. Additional details are available on the gallium nitrate profile page.

US Patents and Regulatory Information for GANITE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chapter 7 Trustee GANITE gallium nitrate INJECTABLE;INJECTION 019961-002 Jan 17, 1991 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Mallinckrodt
Fuji
Federal Trade Commission
Cerilliant
Johnson and Johnson
AstraZeneca
Express Scripts
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot